Bax Mediates the Apoptosis-Sensitizing Effect of Maspin

Cancer Research

Volumn 64, Issue 5, 2004, Pages 1703-1711

  Liu, Jiayou ^a   Yin, Shuping ^a   Reddy, Neelima ^a   Spencer, Craig ^a   Sheng, Shijie ^a,b  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b KARMANOS CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 8; CASPASE 9; CYTOCHROME C; MASPIN; PROTEIN BAK; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL XL; SECOND MITOCHONDRIAL ACTIVATOR OF CASPASE; SERINE PROTEINASE INHIBITOR; SMALL INTERFERING RNA; APOPTOSIS REGULATORY PROTEIN; BAX PROTEIN, HUMAN; BIRC4 PROTEIN, HUMAN; CASP3 PROTEIN, HUMAN; CASP8 PROTEIN, HUMAN; CASP9 PROTEIN, HUMAN; CASPASE; CASPASE 3; MEMBRANE PROTEIN; ONCOPROTEIN; PROTEIN; TNFSF10 PROTEIN, HUMAN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; X LINKED INHIBITOR OF APOPTOSIS;

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER RESISTANCE; CONTROLLED STUDY; CYTOSOL; DRUG MECHANISM; ENDOPLASMIC RETICULUM; ENZYME INHIBITION; HUMAN; HUMAN CELL; IN VIVO STUDY; METASTASIS; MITOCHONDRION; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN DEGRADATION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN TARGETING; UPREGULATION; ENZYME ACTIVATION; MALE; METABOLISM; PATHOLOGY; PHYSIOLOGY; PROSTATE TUMOR; TUMOR SUPPRESSOR GENE;

APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BCL-2-ASSOCIATED X PROTEIN; CASPASE 3; CASPASE 8; CASPASE 9; CASPASES; ENZYME ACTIVATION; GENES, TUMOR SUPPRESSOR; HUMANS; MALE; MEMBRANE GLYCOPROTEINS; MITOCHONDRIA; PROSTATIC NEOPLASMS; PROTEINS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; SERPINS; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TUMOR NECROSIS FACTOR-ALPHA; X-LINKED INHIBITOR OF APOPTOSIS PROTEIN;

EID: 1642274517     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-03-2568     Document Type: Article

References (61)

1. Cher, M., Biliran, H. R, Jr., Bhagat, S., Meng, Y., Che, M., Lockett, J., Abrams, J., Fridman, R., Zachareas, M., and Sheng, S. Maspin expression inhibits osteolysis, tumor growth, and angiogenesis in a model of prostate cancer bone metastasis. Proc. Natl. Acad. Sci. USA, 100: 7847-7852, 2003.
2. Sheng, S., Carey, J., Seftor, E., Dias, L., Hendrix, M. J. C., and Sager, R. Maspin acts at the cell membrane to inhibit invasion and motility of mammary and prostate carcinoma cells. Proc. Natl. Acad. Sci. USA, 93: 11669-11674, 1996.
3. Zhang, M., Volpert, O., Shi, Y. H., and Bouck, N. Maspin is an angiogenesis inhibitor. Nat. Med., 6: 196-199, 2000.
4. Zou, Z., Anisowicz, A., Hendrix, M. J. C., Thor, A., Neveu, M., Sheng, S., Rafidi, K., Seftor, E., and Sager, R. Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells. Science (Wash. DC), 263: 526-529, 1994.
5. Biliran, H. J., and Sheng, S. Pleiotrophic inhibition of pericellular urokinase-type plasminogen activator system by endogenous tumor suppressive maspin. Cancer Res., 61: 8676-8682, 2001.
6. McGowen, R., Biliran, H., Jr., Sager, R, and Sheng, S. The surface of prostate carcinoma DU145 cells mediates the inhibition of urokinase-type plasminogen activator by maspin. Cancer Res., 60: 4771-4778, 2000.
7. Abraham, S., Zhang, W., Greenberg, N., and Zhang, M. Maspin functions as tumor suppressor by increasing cell adhesion to extracellular matrix in prostate tumor cells. J. Urol., 169: 1157-1161, 2003.
8. Seftor, R., Seftor, E. A., Sheng, S., Pemberton, P. A., Sager, R., and Hendrix, M. J. Maspin suppresses the invasive phenotype of human breast carcinoma. Cancer Res., 58: 5681-5685, 1998.
9. Sheng, S. The urokinase-type plasminogen activator system in prostate cancer metastasis. Cancer Metastasis Rev., 20: 287-296, 2001.
10. Chen, Z., Fa, Z., McNeal, J. E., Nolley, R., Caldwell, M. C., Mahadevappa, M., Zhang, Z., Warrington, J. A., and Stamey, T. A. Hepsin and maspin are inversely expressed in laser capture microdissectioned prostate cancer. J. Urol., 169: 1316-1319, 2003.
11. Pierson, C., McGowen, R., Grignon, D., Sakr, W., Dey, J., and Sheng, S. Maspin is up-regulated in premalignant prostate epithelia. Prostate, 53: 255-262, 2002.
12. Jiang, N., Meng, Y., Zhang, S, Mensah-Osman, E., and Sheng, S. Maspin sensitizes breast carcinoma cells to induced apoptosis. Oncogene, 21: 4089-4098, 2002.
13. Sheng, S., Pemberton, P. A., and Sager, R. Production, purification, and characterization of recombinant maspin proteins. J. Biol. Chem., 269: 30988-30993, 1994.
14. Green, D., and Reed, J. C. Mitochondria and apoptosis. Science (Wash. DC), 281: 1309-1312, 1998.
15. Green, D. Apoptotic pathways: the roads to ruin. Cell, 94: 695-698, 1998.
16. Adams, J., and Cory, S. The Bcl-2 protein family: arbiters of cell surviral. Science (Wash. DC), 281: 1322-1325, 1998.
17. Zhou, H., Bolon, I., Nichols, A., Wohlwend, A., and Vassalli, J. D. Overexpression of plasminogen activator inhibitor type 2 in basal keratinocytes enhances papilloma formation in transgenic mice. Cancer Res., 61: 970-976, 2001.
18. Liu, X., Kim, C. N., Yang, J., Jemmerson, R., and Wang, X. Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell, 86: 147-157, 1996.
19. Li, P., Nijhawan, D., Budihardjo, I., Srinivasula, S. M., Ahmad, M., Alnemri, E. S., and Wang, X. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell, 91: 479-489, 1997.
20. Du, C., Fang, M., Li, Y., Li, L., and Wang, X. Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell, 102: 33-42, 2000.
21. Verhagen, A., Ekert, P. G., Pakusch, M., Silke, J., Connolly, L. M., Reid, G. E., Moritz, R. L., Simpson, R. J., and Vaux, D. L. Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins. Cell, 102: 43-53, 2000.
22. Liu, J., Yao, F., Wu, R., Morgan, M., Thorburn, A., Finley, R. L., Jr., and Chen, Y. Q. Mediation of the DCC apoptotic signal by DIP13α. J. Biol. Chem., 277: 26281-26285, 2002.
23. Deng, Y., and Wu, X. Peg3/Pw1 promotes P53-mediated apoptosis by inducing Bax translocation from cytosol to mitochondria. Proc. Natl. Acad. Sci. USA, 97: 12050-12055, 2000.
24. Duan, S., Hajek, P., Lin, C., Shin, S. K., Attardi, G., and Chomyn, A. Mitochondrial outer membrane permeability change and hypersensitivity to digitonin early in staurosporine-induced apoptosis. J. Biol. Chem., 278: 1346-1353, 2003.
25. Smyth, M., Takeda, K., Hayakawa, Y., Peschon, J. J., van den Brink, M. R., and Yagita, H. Nature's TRAIL: on a path to cancer immunotherapy. Immunity, 18: 1-6, 2003.
26. Nakagawa, T., Zhu, H., Morishima, N., Li, E., Xu, J., Yankner, B. A., and Yuan, J. Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-β. Nature (Lond.), 403: 98-103, 2000.
27. Kuida, K. Caspase-9. Int J Biochem. Cell Biol., 32: 121-124, 2000.
28. Kruidering, M., and Evan, G. I. Caspase-8 in apoptosis: the beginning of "the end"? IUBMB Life, 50: 85-90, 2000.
29. Gregoli, P., and Bondurant, M. C. Function of caspases in regulating apoptosis caused by erythropoietin deprivation in erythroid progenitors. J. Cell Physiol., 178: 133-143, 1999.
30. Schrantz, N., Blanchard, D. A., Auffredou, M. T., Sharma, S., Leca, G., and Vazquez, A. Role of caspases and possible involvement of retinoblastoma protein during TGFβ-mediated apoptosis of human B lymphocytes. Oncogene, 18: 3511-3519, 1999.
31. Wang, X. The expanding role of mitochondria in apoptosis. Genes Dev., 15: 2922-2933, 2001.
32. Gabriel, C., Ali, C., Lesne, S., Fernandez-Monreal, M., Docagne, F., Plawinski, L., MacKenzie, E. T., Buisson, A., and Vivien, D. Transforming growth factor α-induced expression of type 1 plasminogen activator inhibitor in astrocytes rescues neurons from excitotoxicity. FASEB J., 17: 277-279, 2003.
33. Dickinson, J., Norris, B. J., Jensen, P. H., and Antalis, T. M. The C-D interhelical domain of the serpin plasminogen activator inhibitor-type 2 is required for protection from TNF-α induced apoptosis. Cell Death Differ., 5: 163-171, 1998.
34. Hardwick, J., and Polster, B. M. Bax, along with lipid conspirators, allows cytochrome c to escape mitochondria. Mol. Cell., 10: 963-965, 2002.
35. Hsu, Y., Wolter, K. G., and Youle, R. J. Cytosol-to-membrane redistribution of Bax and Bcl-XL during apoptosis. Proc. Natl. Acad. Sci. USA, 94: 3668-3672, 1997.
36. Wolter, K., Hsu, Y. T., Smith, C. L., Nechushtan, A., Xi, X. G., and Youle, R. J. Movement of Bax from the cytosol to mitochondria during apoptosis. J. Cell Biol., 139: 1281-1292, 1997.
37. Csordas, G., Thomas, A. P., and Hajnoczky, G. Quasi-synaptic calcium signal transmission between endoplasmic reticulum and mitochondria. EMBO J., 18: 96-108, 1999.
38. Lam, M., Dubyak, G., Chen, L., Nunez, G., Miesfeld, R. L., and Distelhorst, C. W. Evidence that BCL-2 represses apoptosis by regulating endoplasmic reticulum-associated Ca2+ fluxes. Proc. Natl. Acad. Sci. USA, 91: 6569-6573, 1994.
39. He, H., Lam, M., McCormick, T. S., and Distelhorst, C.W. Maintenance of calcium homeostasis in the endoplasmic reticulum by Bcl-2. J. Cell Biol., 138: 1219-1228, 1997.
40. Kuo, T., Kim, H. R., Zhu, L., Yu, Y., Lin, H. M., and Tsang, W. Modulation of endoplasmic reticulum calcium pump by Bcl-2. Oncogene, 17: 1903-1910, 1998.
41. Murphy, A., Bredesen, D. E., Cortopassi, G., Wang, E., and Fiskum, G. Bcl-2 potentiates the maximal calcium uptake capacity of neural cell mitochondria. Proc. Natl. Acad. Sci. USA, 93: 9893-9898, 1996.
42. Foyouzi-Youssefi, R., Arnaudeau, S., Borner, C., Kelley, W. L., Tschopp, J., Lew, D. P., Demaurex, N., and Krause, K. H. Bcl-2 decreases the free Ca2+ concentration within the endoplasmic reticulum. Proc. Natl. Acad. Sci. USA, 97: 5723-5728, 2000.
43. Ashkenazi, A., Pai, R. C., Fong, S., Leung, S., Lawrence, D. A., Marsters, S. A., Blackie, C., Chang, L., McMurtrey, A. E., Hebert, A., et al. Safety and antitumor activity of recombinant soluble Apo2 ligand. J. Clin. Investig., 104: 155-162, 1999.
44. Ashkenazi, A. Targeting death and decoy receptors of the tumour-necrosis factor superfamily. Nat. Rev. Cancer, 2: 420-430, 2002.
45. Stegh, A., Barnhart, B. C., Volkland, J., Algeciras-Schimnich, A., Ke, N., Reed, J. C., and Peter, M. E. Inactivation of caspase-8 on mitochondria of Bcl-xL-expressing MCF7-Fas cells: role for the bifunctional apoptosis regulator protein. J. Biol. Chem., 277: 4351-4360, 2002.
46. Li, H., Zhu, H., Xu, C., and Yuan, J. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell, 94: 491-501, 1998.
47. Luo, X., Budihardjo, I., Zou, H., Slaughter, C., and Wang, X. Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell, 94: 481-490, 1998.
48. Stegh, A., Herrmann, H., Lampel, S., Weisenberger, D., Andra, K., Seper, M., Wiche, G., Krammer. P. H., and Peter, M. E. Identification of the cytolinker plectin as a major early in vivo substrate for caspase 8 during CD95- and tumor necrosis factor receptor-mediated apoptosis. Mol. Cell. Biol., 20: 5665-5679, 2000.
49. Kagawa, S., Gu, J., Swisher, S. G., Ji, L., Roth, J. A., Lai, D., Stephens, L. C., and Fang, B. Antitumor effect of adenovirus-mediated Bax gene transfer on p53-sensitive and p53-resistant cancer lines. Cancer Res., 60: 1157-1161, 2000.
50. Odero-Marah, V., Khalkhali-Ellis, Z., Schneider, G. B., Seftor, E. A., Seftor, R. E., Koland, J. G., and Hendrix, M. J. Tyrosine phosphorylation of maspin in normal mammary epithelia and breast cancer cells. Biochem. Biophys. Res. Commun., 295: 800-805, 2002.
51. Sood, A., Fletcher, M. S., Gruman, L. M., Coffin, J. E., Jabbari, S., Khalkhali-Ellis, Z., Arbour, N., Seftor, E. A., and Hendrix, M. J. C. The paradoxical expression of maspin in ovarian carcinoma. Clin. Cancer Res., 8: 2924-2932, 2002.
52. Harris, C., Maroney, A. C., and Johnson, E. M., Jr. Identification of JNK-dependent and -independent components of cerebellar granule neuron apoptosis. J. Neurochem., 83: 992-1001, 2002.
53. Hay, E., Lemonnier, J., Fromigue, O., and Marie, P. J. Bone morphogenetic protein-2 promotes osteoblast apoptosis through a Smad-independent, protein kinase C-dependent signaling pathway. J. Biol. Chem., 276: 29028-29036, 2001.
54. Aguirre-Ghiso, J., Liu, D., Mignatti, A., Kovalski, K., and Ossowski, L. Urokinase receptor and fibronectin regulate the ERK(MAPK) to p38(MAPK) activity ratios that determine carcinoma cell proliferation or dormancy in vivo. Mol. Biol. Cell, 12: 863-879, 2001.
55. Aguirre-Ghiso, J., Estrada, Y., Liu, D., and Ossowski, L. ERK(MAPK) activity as a determinant of tumor growth and dormancy; regulation by p38(SAPK). Cancer Res., 63: 1684-1695, 2003.
56. Roth, W., and Reed, J. C., Apoptosis and cancer: when BAX is TRAILing away. Nat. Med., 8: 216-218, 2002.
57. Vitolo, D., Zerbe, T., Kanbour, A., Dahl, C., Herberman, R. B., and Whiteside, T. L., Expression of mRNA for cytokines in tumor-infiltrating mononuclear cells in ovarian adenocarcinoma and invasive breast cancer. Int. J. Cancer, 51: 573-580, 1992.
58. Silberstein, G. Tumour-stromal interactions: role of the stroma in mammary development. Breast Cancer Res., 3: 218-223, 2001.
59. Tuxhorn, J., Ayala, G. E., and Rowley, DR. Reactive stroma in prostate cancer progression. J. Urol., 166: 2472-2483, 2001.
60. Rowley, D. What might a stromal response mean to prostate cancer progression? Cancer Metastasis Rev., 17: 411-419, 1998-99.
61. Li, J., Colburn, N. H., and Oberley, L. W. Maspin gene expression in tumor suppression induced by overexpressing manganese-containing superoxide dismutase cDNA in human breast cancer cells. Carcinogenesis, 19: 833-839, 1998.